Systemic inflammatory biomarkers in Schizophrenia are changed by ECT administration and related to the treatment efficacy

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Immune inflammation has long been implicated in the pathogenesis of schizophrenia. Despite as a rapid and effective physical therapy, the role of immune inflammation in electroconvulsive therapy (ECT) for schizophrenia remains elusive. The neutrophils to lymphocytes (NLR), platelets to monocytes (PLR) and monocytes to lymphocytes (MLR) are inexpensive and accessible biomarkers of systemic inflammation. In this study, 70 schizophrenia patients and 70 age- and sex-matched healthy controls were recruited. The systemic inflammatory biomarkers were measured before and after ECT. Our results indicated schizophrenia had significantly higher peripheral NLR, PLR and MLR compared to health controls at baseline, while lymphocytes did not differ. After 6 ECT, the psychiatric symptoms were significantly improved, as demonstrated by the Positive and Negative Syndrome Scale (PANSS). However, there was a decline in cognitive function scores, as indicated by the Mini-Mental State Examination (MMSE). Notably, the neutrophils and NLR were significantly reduced following ECT. Although lymphocytes remained unchanged following ECT, responders had significantly higher lymphocytes compared to non-responders. Moreover, the linear regression analyses revealed that higher lymphocytes served as a predictor of larger improvement in positive symptom following ECT. Overall, our findings further highlighted the presence of systemic inflammation in schizophrenia patients, and that ECT may exert a therapeutic effect in part by attenuating systemic inflammation. Further research may therefore lead to new treatment strategies for schizophrenia targeting the immune system.
Funding Information
  • The National Natural Science Foundation of China (81971255)
  • Social Development Foundation of Jiangsu Province, China (No. BE2019610)
  • the key project supported by medical science and technology development foundation, nanjing department of health (YKK20090)
  • The Science and Technology Development Program of Nanjing Medical University (NMUB2019107)
  • the National NaturalScience Foundation of China (82371510)
  • Nanjing Major Science and Technology Project (No 202305035)
  • Medical Science and Technology Innovation Project of Xu’zhou Health Commission for Young Scholars (No.XWKYHT20200064)

This publication has 59 references indexed in Scilit: